Serine 312 phosphorylation is dispensable for wild-type p53 functions in vivo

被引:0
|
作者
M K Lee
W M Tong
Z Q Wang
K Sabapathy
机构
[1] Laboratory of Molecular Carcinogenesis,Division of Cellular & Molecular Research
[2] Humphrey Oei Institute of Cancer Research,Department of Biochemistry
[3] National Cancer Centre,undefined
[4] 11,undefined
[5] Hospital Drive,undefined
[6] Singapore 169610,undefined
[7] Singapore,undefined
[8] Institute of Basic Medical Sciences School of Basic Medicine,undefined
[9] Chinese Academy of Medical Sciences Peking Union Medical College 5,undefined
[10] Leibniz Institute for Age Research – Fritz Lipmann Institute e.V.,undefined
[11] Biology and Pharmacy Faculty,undefined
[12] Friedrich-Schiller-University,undefined
[13] Cancer and Stem Cell Biology Program,undefined
[14] Duke-NUS Graduate Medical School,undefined
[15] Duke-NUS Graduate Medical School,undefined
[16] National University of Singapore,undefined
来源
Cell Death & Differentiation | 2011年 / 18卷
关键词
ER-stress; p53; phosphorylation; protein stability; S312;
D O I
暂无
中图分类号
学科分类号
摘要
Cellular stimulation results in phosphorylation of the tumor suppressor p53 on multiple residues, though the functional relevance is not always clear. It is noteworthy that the serine (S) 315 residue is unique, as it has been suggested to be phosphorylated not only by genotoxic signals, but also during cell-cycle progression and by endoplasmic-reticulum stress. However, in vitro data have been conflicting as phosphorylation at this site was shown to both positively and negatively regulate p53 functions. We have thus generated knock-in mice expressing an unphosphorylable S312 (equivalent to human S315), by substitution with an alanine (A) residue, to clarify the conflicting observations and to evaluate its functional relevance in vivo. Born at Mendelian ratios, the p53S312A/S312A mice show no anomalies during development and adulthood. p53 activation, stability, localization and ability to induce apoptosis, cell-cycle arrest and prevent centrosome amplification are not compromised in p53S312A/S312A cells. p53S312A/S312A mice are unable to rescue mdm2−/− lethality, and tumorigenesis – both spontaneous and irradiation/oncogene-induced – is not accentuated. Taken together, the results show that the S312 phosphorylation site is not in itself necessary for efficient p53 function, and advocates the possibility that it is neither relevant in the mouse context nor important for p53 functions in vivo.
引用
收藏
页码:214 / 221
页数:7
相关论文
共 50 条
  • [1] Serine 312 phosphorylation is dispensable for wild-type p53 functions in vivo
    Lee, M. K.
    Tong, W. M.
    Wang, Z. Q.
    Sabapathy, K.
    CELL DEATH AND DIFFERENTIATION, 2011, 18 (02): : 214 - 221
  • [2] Inhibition of mutant p53 phosphorylation at serine 15 or serine 315 partially restores the function of wild-type p53
    Sugikawa, E
    Yazaki, N
    Tsunoda, S
    Nakanishi, N
    Ohashi, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (02) : 256 - 263
  • [3] In the right place at the right time Analysis of p53 serine 312 phosphorylation in vivo
    Slee, Elizabeth A.
    Lu, Xin
    CELL CYCLE, 2011, 10 (09) : 1345 - 1346
  • [4] SERINE MUTANTS OF HUMAN P53 IN THE ACTIVATION DOMAIN ARE WILD-TYPE FOR TRANSFORMATION SUPPRESSION AND TRANSACTIVATION FUNCTIONS
    UNGER, T
    SCHEFFNER, M
    YEE, CL
    HOWLEY, PM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 184 - 184
  • [5] Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo
    Palacios, G.
    Moll, U. M.
    ONCOGENE, 2006, 25 (45) : 6133 - 6139
  • [6] Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo
    G Palacios
    U M Moll
    Oncogene, 2006, 25 : 6133 - 6139
  • [7] Disruption of functions of wild-type p53 by hetero-oligomerization
    Deb, D
    Chakraborti, AS
    Lányi, A
    Troyer, DA
    Deb, S
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 15 (03) : 413 - 422
  • [8] COTRANSLATION OF ACTIVATED MUTANT P53 WITH WILD-TYPE DRIVES THE WILD-TYPE P53 PROTEIN INTO THE MUTANT CONFORMATION
    MILNER, J
    MEDCALF, EA
    CELL, 1991, 65 (05) : 765 - 774
  • [9] THE CARBOXY-TERMINAL SERINE-392 PHOSPHORYLATION SITE OF HUMAN P53 IS NOT REQUIRED FOR WILD-TYPE ACTIVITIES
    FISCELLA, M
    ZAMBRANO, N
    ULLRICH, SJ
    UNGER, T
    LIN, D
    CHO, B
    MERCER, WE
    ANDERSON, CW
    APPELLA, E
    ONCOGENE, 1994, 9 (11) : 3249 - 3257
  • [10] Activities of wild-type and mutant p53
    Vousden, Karen H.
    CANCER RESEARCH, 2013, 73